Evaluation of annexin A5 as a biomarker for Alzheimer's disease and dementia with lewy bodies

Background: Alzheimer's disease (AD) differs from other forms of dementia in its relation to amyloid beta peptide (Aβ(42)). Using a cell culture model we previously identified annexin A5, a Ca(2+), and phospholipid binding protein, as an AD biomarker. Plasma level of annexin A5 was significantl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohma, Hitoshi, Imai, Shin-ichi, Takei, Norio, Honda, Hirohito, Matsumoto, Kyoichi, Utsumi, Kumiko, Matsuki, Kayo, Hashimoto, Eri, Saito, Toshikazu, Kokai, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617410/
https://www.ncbi.nlm.nih.gov/pubmed/23576984
http://dx.doi.org/10.3389/fnagi.2013.00015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617410/
https://www.ncbi.nlm.nih.gov/pubmed/23576984
http://dx.doi.org/10.3389/fnagi.2013.00015

Ejemplares similares